Abstract: The present invention is directed to anti-IL18-BP antibodies and uses thereof. The present invention is directed to monotherapy and combination treatments with for example immune checkpoint inhibitor antibodies, as described herein.
| # | Name | Date |
|---|---|---|
| 1 | 202417064846-STATEMENT OF UNDERTAKING (FORM 3) [28-08-2024(online)].pdf | 2024-08-28 |
| 3 | 202417064846-Sequence Listing in PDF [28-08-2024(online)].pdf | 2024-08-28 |
| 4 | 202417064846-REQUEST FOR EXAMINATION (FORM-18) [28-08-2024(online)].pdf | 2024-08-28 |
| 5 | 202417064846-NOTIFICATION OF INT. APPLN. NO. & FILING DATE (PCT-RO-105-PCT Pamphlet) [28-08-2024(online)].pdf | 2024-08-28 |
| 6 | 202417064846-FORM 18 [28-08-2024(online)].pdf | 2024-08-28 |
| 7 | 202417064846-FORM 1 [28-08-2024(online)].pdf | 2024-08-28 |
| 8 | 202417064846-DRAWINGS [28-08-2024(online)].pdf | 2024-08-28 |
| 9 | 202417064846-DECLARATION OF INVENTORSHIP (FORM 5) [28-08-2024(online)].pdf | 2024-08-28 |
| 10 | 202417064846-COMPLETE SPECIFICATION [28-08-2024(online)].pdf | 2024-08-28 |
| 11 | 202417064846-FORM-26 [29-08-2024(online)].pdf | 2024-08-29 |
| 12 | 202417064846-Proof of Right [26-09-2024(online)].pdf | 2024-09-26 |
| 13 | 202417064846-RELEVANT DOCUMENTS [14-10-2024(online)].pdf | 2024-10-14 |
| 14 | 202417064846-MARKED COPIES OF AMENDEMENTS [14-10-2024(online)].pdf | 2024-10-14 |
| 15 | 202417064846-FORM 13 [14-10-2024(online)].pdf | 2024-10-14 |
| 16 | 202417064846-AMMENDED DOCUMENTS [14-10-2024(online)].pdf | 2024-10-14 |
| 17 | 202417064846-FORM 3 [03-02-2025(online)].pdf | 2025-02-03 |